Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation

Stem Cells

Volumn 27, Issue 10, 2009, Pages 2373-2382

  Dufour, Christelle ^a,b   Cadusseau, Josette ^c   Varlet, Pascale ^a,d   Surena, Anne Laure ^a   De Faria, Giselle P ^a,e   Dias Morais, Amelie ^a   Auger, Nathalie ^b   Léonard, Nadine ^a,d   Daudigeos, Estelle ^b   Dantas Barbosa, Carmela ^b   Grill, Jacques ^b   Lazar, Vladimir ^b   Dessen, Philippe ^b,f   Vassal, Gilles ^b   Prevot, Vincent ^g   Sharif, Ariane ^g   Chneiweiss, Herve ^a   Junier, Marie Pierre ^a,d  

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSERM U955   (France)

^d CENTRE HOSPITALIER SAINTE ANNE   (France)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g UNIV LILLE   (France)

Author keywords

Epidermal growth factor; erbB; Metaplasia; Radial glia; Transdifferentiation

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CANCER GRAFT; CELL DEDIFFERENTIATION; CELL IMMORTALIZATION; CELL STRESS; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOGENETICS; FEMALE; GAMMA IRRADIATION; GLIOMA; IRRADIATION; MALE; MALIGNANT TRANSFORMATION; MOUSE; NEURAL STEM CELL; NONHUMAN;

ANIMALS; ASTROCYTES; BRAIN NEOPLASMS; CELL DEDIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; GAMMA RAYS; GLIOMA; MICE; MICE, INBRED C57BL; MICE, NUDE; STEM CELL TRANSPLANTATION; STEM CELLS; STRESS, PHYSIOLOGICAL; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 70350216061     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.155     Document Type: Article

References (49)

1. Collins VP. Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry 2004;75:ii2-ii11.
2. Singh SK, Clarke ID, Hide T et al. Cancer stem cells in nervous system tumors. Oncogene 2004;23:7267-7273. (Pubitemid 39382160)
3. Galli R, Binda E, Orfanelli U et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-7021. (Pubitemid 39331011)
4. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005;353:811-822.
5. Shih AH, Holland EC. Developmental neurobiology and the origin of brain tumors. J Neurooncol 2004;70:125-136.
6. Harris H. Tumour suppression: putting on the brakes. Nature 2004; 427:201.
7. Lee DC, Fenton SE, Berkowitz EA et al. Transforming growth factor alpha: expression, regulation, and biological activities. Pharmacol Rev 1995;47:51-85.
8. Sharif A, Legendre P, Prevot V et al. Transforming growth factor alpha promotes sequential conversion of mature astrocytes into neural progenitors and stem cells. Oncogene 2007;26:2695-2706. (Pubitemid 46663827)
9. Junier MP. What role(s) for TGFalpha in the central nervous system? Prog Neurobiol 2000;62:443-473.
10. Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci 2001;24:385-428.
11. Rabchevsky AG, Weinitz JM, Coulpier M, et al. A role for transforming growth factor alpha as an inducer of astrogliosis. J Neurosci 1998; 18:10541-10552. (Pubitemid 29016573)
12. Bachoo RM, Maher EA, Ligon KL et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002;1:269-277.
13. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
14. Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;3:595-605.
15. Buffo A, Rite I, Tripathi P et al. Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain. Proc Natl Acad Sci U S A 2008;105:3581-3586. (Pubitemid 351723595)
16. Prevot V, Lomniczi A, Corfas G, et al. erbB-1 and erbB-4 receptors act in concert to facilitate female sexual development and mature reproductive function. Endocrinology 2005;146:1465-1472. (Pubitemid 40289336)
17. Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005;6:32-43.
18. Surena AL, de Faria GP, Studler JM et al. DLG1/SAP97 modulates transforming growth factor alpha bioavailability. Biochim Biophys Acta 2009;1793:264-272.
19. Yaish P, Gazit A, Gilon C et al. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science 1988;242: 933-935. (Pubitemid 19015255)
20. Sharif A, Prevot V, Renault-Mihara F et al. Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes. Oncogene 2006;25:4076-4085. (Pubitemid 44024870)
21. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press; 1997.
22. Boillee S, Cadusseau J, Coulpier M et al. Transforming growth factor alpha: a promoter of motoneuron survival of potential biological relevance. J Neurosci 2001;21:7079-7088. (Pubitemid 32846955)
23. Sharif A, Renault F, Beuvon F et al. The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience 2004;126:263-275. (Pubitemid 38780802)
24. Chiarugi P, Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 2003;28:509-514. (Pubitemid 38340416)
25. Contessa JN, Reardon DB, Todd D et al. The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells. Clin Cancer Res 1999;5:405-411. (Pubitemid 29085194)
26. Dent P, Reardon DB, Park JS et al. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell 1999;10:2493-2506. (Pubitemid 29393505)
27. Reardon DB, Contessa JN, Mikkelsen RB et al. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene 1999;18:4756-4766.
28. Cooper GM, Okenquist S, Silverman L. Transforming activity of DNA of chemically transformed and normal cells. Nature 1980;284: 418-421. (Pubitemid 10121314)
29. Louis SA, Rietze RL, Deleyrolle L et al. Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay. Stem Cells 2008;26:988-996.
30. Polito A, Reynolds R. NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat 2005;207:707-716. (Pubitemid 43019730)
31. Todaro GJ, Fryling C, De Larco JE. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A 1980; 77:5258-5262. (Pubitemid 11195545)
32. Watanabe S, Lazar E, Sporn MB. Transformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying a synthetic rat type alpha transforming growth factor gene. Proc Natl Acad Sci U S A 1987;84:1258-1262. (Pubitemid 17027332)
33. Shankar V, Ciardiello F, Kim N et al. Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA. Mol Carcinog 1989;2:1-11. (Pubitemid 19148369)
34. Sandgren EP, Luetteke NC, Palmiter RD et al. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990;61: 1121-1135. (Pubitemid 20203494)
35. Jhappan C, Stahle C, Harkins RN et al. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990;61:1137-1146. (Pubitemid 20203495)
36. Matsui Y, Halter SA, Holt JT et al. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell 1990;61:1147-1155. (Pubitemid 20203496)
37. Yahanda AM, Bruner JM, Donehower LA et al. Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol Cell Biol 1995;15:4249-4259.
38. Bogler O, Nagane M, Gillis J et al. Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro. Cell Growth Differ 1999;10:73-86. (Pubitemid 29093920)
39. Baumann M, Krause M, Dikomey E et al. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms. Radiother Oncol 2007;83:238-248. (Pubitemid 46915540)
40. Geoerger B, Gaspar N, Opolon P et al. EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts. Int J Cancer 2008;123:209-216. (Pubitemid 351705211)
41. Schmidt-Ullrich RK, Contessa JN, Dent P et al. Molecular mechanisms of radiation-induced accelerated repopulation. Radiat Oncol Investig 1999;7:321-330. (Pubitemid 30033351)
42. Dent P, Yacoub A, Contessa J et al. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res Mar 2003;159:283-300. (Pubitemid 36314943)
43. Sturla LM, Amorino G, Alexander MS et al. Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. J Biol Chem 2005;280:14597-14604. (Pubitemid 40562804)
44. Schmidt MH, Furnari FB, Cavenee WK, Bogler O. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization. Proc Natl Acad Sci U S A 2003;100:6505-6510. (Pubitemid 36666611)
45. Szumiel I. Epidermal growth factor receptor and DNA double strand break repair: the cell's self-defence. Cell Signal 2006;18:1537-1548. (Pubitemid 44216136)
46. Shoshan Y, Nishiyama A, Chang A et al. Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. Proc Natl Acad Sci U S A 1999;96:10361-10366. (Pubitemid 29422563)
47. Chekenya M, Krakstad C, Svendsen A et al. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene 2008;27:5182-5194.
48. Burg MA, Nishiyama A, Stallcup WB. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp Cell Res 1997;235: 254-264. (Pubitemid 27381704)
49. Walton NM, Snyder GE, Park D et al. Gliotypic neural stem cells transiently adopt tumorigenic properties during normal differentiation. Stem Cells 2009;27:280-289.